Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 54 , ISSUE 2 ( April-June, 2020 ) > List of Articles

Original Article

Analysis of Time Trend of Cost of Medications

Rajan Bhagat

Keywords : Commonly used drugs, Drug price, Increase over time

Citation Information : Bhagat R. Analysis of Time Trend of Cost of Medications. J Postgrad Med Edu Res 2020; 54 (2):34-36.

DOI: 10.5005/jp-journals-10028-1357

License: CC BY-NC 4.0

Published Online: 07-10-2020

Copyright Statement:  Copyright © 2020; The Author(s).


Background: Increase in prices of drugs has always been a topic of concern across the world. In countries like India, where people have to bear this expenditure out of pocket, rise in prices of drugs is a major issue. Objective: To find out the pattern of changes in prices of some commonly used drugs over a period of 15 years. Materials and methods: We selected some commonly used drugs used in the treatment of cardiovascular system (CVS), central nervous system (CNS), respiratory, hematological, gastrointestinal, and endocrine diseases. We also included some other drugs like antimicrobials, anti-allergics, and nonsteroidal anti-inflammatory drugs (NSAIDs). Information on the prices of drugs was extracted at four time points: years 2001, 2006, 2011, and 2016. Percentage change in prices over a period of 15 years was calculated. We followed the time course of price variation of the same dosing strengths of the highest and lowest priced brands, out of the various brands available. We categorized the drugs into three categories: more than or equal to 100% increase in price, “decrease” and “no change.” Results: Out of total 117 drugs, 28 drugs (24%) showed an increase of more than 100% over this period. Among lowest priced brands, there was a mean [standard deviation (SD)] increase of 222% (142), and among highest priced brands, there was an average increase of 244% (205). Fifty-nine (50%) drugs showed “no change” or “decrease” in price, the reason for which in 31 (52.5%) came under price control. Conclusion: Since the prices of raw materials tend to decline over time, the hike in drug prices appears unjustified.

  1. Drug Goes From $13.50 a Tablet to $750, Overnight.…/a-huge-overnight-increase-in-a-drugs-price-raises-protests. Accessed Sep 20, 2016.
  2. 5 things we learned from EpiPen price hike hearing.…/90827270/. Accessed Sep 22, 2016.
  3. Kotwani A, Ewen M, Dey D, et al. Medicine prices and availability at six sites in India: using WHO-HAI medicine prices methodology. Indian J Med Res 2007;125(5):645–654.
  4. Berman P, Ahuja R, Bhandari L. The impoverishing effect of healthcare payments in India: new methodology and findings. Econ Polit Wkly 2010;45:65–71.
  5. National Pharmaceutical Pricing Authority: Whats New. Accessed January 17, 2017.
  6. Compendium of Prices - NPPA. Accessed January 15, 2017.
  7. Alpern JD, Stauffer WM, Kesselheim AS. High-cost generic drugs: implications for patients and policymakers. N Engl J Med 2014;371(20):1859–1862. DOI: 10.1056/NEJMp1408376.
  8. Hauptman PJ, Goff ZD, Vidic A, et al. Variability in Retail Pricing of Generic Drugs for Heart Failure. JAMA 2016.
  9. Historic inflation India – historic CPI inflation India - Accessed January 20, 2017.
  10. Exploratory Study on Active Pharmaceutical Ingredient Manufacturing for Essential Medicines. > All > Quality and Safety: Medicines > Quality Assurance. Accessed January 20, 2017.
  11. National Health Expenditures 2015 Highlights.…/nationalhealthexpenddata/…/highlights.pdf. Accessed January 28, 2017.
  12. National Pharmaceutical Pricing Authority slashes stent prices by up to 85%. > India News. Accessed February 20, 2017.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.